It is clinically important to underline that eotaxin-1 cannot mobilize eosinophils without synergia with IL-5, meaning that blocking IL-5 is far more crucial treatment-wise, since eotaxin-1 alone can only lead to blood eosinophilia but not to tissue infiltration. The gene discussed is IL5; the disease is Increased total eosinophil count.